Drug use evaluation of ceftriaxone in medical ward of Dessie Referral Hospital, North East Ethiopia

Authors

  • Getasew A. Ayinalem Department of Pharmacy, College of Medicine and Health Sciences, Ambo University, Ambo, Ethiopia
  • Belayneh K. Gelaw Department of Pharmacy, College of Medicine and Health Sciences, Ambo University, Ambo, Ethiopia
  • Abebe Z. Belay Department of Pharmacy, College of Medicine and Health Sciences, Ambo University, Ambo, Ethiopia
  • Jimma L. Linjesa Department of Pharmacy, College of Medicine and Health Sciences, Ambo University, Ambo, Ethiopia

Keywords:

Ceftriaxone, Drug use evaluation, Dessie, STGs (Standard treatment guidelines), DRH

Abstract

Background: Assessment of antimicrobial use can be performed by evaluating their use. Drug use evaluation is a performance improvement method that focuses on evaluation and improvement of drug use processes to achieve optimal patient outcomes. The objective of this study was to evaluate the rational use of ceftriaxone in Medical ward of Dessie referral Hospital, Dessie-Ethiopia.

Methods: Retrospective systematic study was used to assess rational use of ceftriaxone. The study was conducted by reviewing medication records of 316 patients, who received ceftriaxone during hospitalization at Medical ward of Dessie referral Hospital from December 30, 2011 to January, 2013. A systematic sampling method was used to select inpatient prescriptions in this ward with ceftriaxone and patient cards were located based on the medical record number on the prescription papers. Data was collected by using structured format and evaluated against WHO criteria for drug use evaluation as per standard treatment guideline of Ethiopia.

Results: Most patients were dosed as 2 g/day (79.4%). The duration of therapy was found to be high in the range 2-7 days (51.69%). Ceftriaxone was mainly used as pneumonia treatment (38.8%). Maintenance fluids were the most commonly co-administered medications with a frequency of 62.16%. The use of ceftriaxone was appropriate only in 170 cases (55.8%) for the justification of use. Most of inappropriate uses were seen in terms of duration during treatment of pneumonia followed by frequency for the treatment of meningitis. Consistency of prescriber to the national standard treatment guideline was found to be low.

Conclusions: To improve rational use and prevent the development of resistance; prescribers should adhere to the national standard treatment guideline. Intensification of short term trainings and antibiotic control systems are some of the possible solutions the hospital has to do.ceftriaxone therapy does not meet the current STG of Ethiopia.

References

Food, Medicine and Health Care Administration

and Control Authority (FMHACA), Ethiopia. Antimicrobial use, resistance and containment baseline survey, syntheses of findings, Aug 2009, Addis Ababa, Ethiopia.

Marion B, Tony M, Jonathan G et al. Ceftriaxone and cefotaxime use in Victorian hospitals, MJA, 2002; 176:524-529.

Romanan L, Zulfigar A, Adriano D et al. Disease control priorities in developing countries, Drug resistance, 2005; 1031-1051.

Hyuck l, Dongsik J, Joon S et al. evaluation of ceftriaxone utilization at multi-center study, DOI: 10, 3904.Kjim, 2009.

American society of health system pharmacists, ASHP. Guideline on medication use evaluation. Am J Health system pharma 1996; 53:1953-5.

SHPA Standard of practice for drug use evaluation in Australian Hospital, J Pharm Pract Res 2004; 34(3):220-3.

The Academy of Managed Care Pharmacy’s, concepts in managed care pharmacy. Drug use evaluation. Alexandria, 2008. Access date: 12/08/ 2011.http://www.amcp.org/workarea/downloadasse.aspx?id=9296.

WHO. Drug and therapeutic committee, A practical guide to drug use evaluation; Drug use evaluation (Drug utilization review), 2003; 155.

Irish medicine board. Ceftriaxone-contraindication in newborns and risk of calcium ceftriaxone precipitation when administered/mixed with solution containing calcium, New clinical, 2010.

David M. Promoting appropriate antimicrobial drug use: perspective from the center for disease control and prevention, Infectious disease society of America, Atlanta, 2007.

William F, Janis E. The cephalosporins, Mayo Clin Proc 1999; 74:187-195.

Christopher J, Denis B. Cephalosporins; A review, Pediatrics in review 2008; 29:264-273.

Laxtey M, Marjonne P, Hema R et al. Third generation cephalosporin use in a tertiary hospital in Port of Spain, Trinidad: Need for an antibiotic policy, Biomed central, 2004.

Michael M, Mulugeta T, Comparative retrospective drug use evaluation of ceftriaxone injection in Police and Black lion Hospitals, EPA, 2009.

Jan E. Antibiotic utilization: Is there an effect on antimicrobial resistance? Chest, 2001: 119; 4285-4305.

Frehiwot Abebe, retrospective drug use evaluation of ceftriaxone in Ayder referral hospital, Ethiopia.

Downloads

Published

2017-02-02

How to Cite

Ayinalem, G. A., Gelaw, B. K., Belay, A. Z., & Linjesa, J. L. (2017). Drug use evaluation of ceftriaxone in medical ward of Dessie Referral Hospital, North East Ethiopia. International Journal of Basic & Clinical Pharmacology, 2(6), 711–717. Retrieved from https://www.ijbcp.com/index.php/ijbcp/article/view/1354

Issue

Section

Original Research Articles